Literature DB >> 26221272

Expression of AKAP95, Cx43, CyclinE1 and CyclinD1 in esophageal cancer and their association with the clinical and pathological parameters.

Shupeng Zhao1, Min Yi2, Yangyang Yuan2, Wenxin Zhuang2, Dengcheng Zhang2, Xiuyi Yu3, Xiaoxuan Chen2, Bogang Teng2, Zhiyu Guan4, Yongxing Zhang2.   

Abstract

OBJECTIVE: To investigate correlations among A-kinase anchor protein95 (AKAP95), Connexin43 (Cx43), CyclinE1 and CyclinD1 in esophageal squamous cell cancer tissues, and their relationship with clinical and pathological parameters.
METHODS: The protein levels of AKAP95, Cx43, CyclinE1 and CyclinD1 in 54 cases of esophageal squamous cell cancer tissues were determined by immunohistochemistry.
RESULTS: The expression of AKAP95, CyclinE1 and CyclinD1 in esophageal squamous cell cancer tissues (53.70%, 88.89%, 72.22%, respectively) was significantly increased when compared to pericarcinoma tissues (20.00%, P < 0.05; 6.67%, P < 0.01; and 20.00%, P < 0.05; respectively). By contrast, Cx43 expression in esophageal squamous cell cancer tissues (22.22%) was lower than that in pericarcinoma tissues (60.00%, P < 0.05). The expression of AKAP95, Cx43, CyclinE1 and CyclinD1 in the tissues of esophageal squamous cell carcinoma was unrelated to lymph node metastasis and the degree of differentiation. The expression of Cx43, CyclinE1, CyclinD1 in the tissues of esophageal squamous cell carcinoma was significantly correlated with AKAP95, respectively (P < 0.05).
CONCLUSION: Expression levels of AKAP95, CyclinE1 and CyclinD1 were higher, and that of Cx43 lower in esophageal squamous cell carcinoma tissues as compared pericarcinoma tissues, which suggests their importance in the incidence and development of esophageal squamous cell carcinoma. The expression of Cx43, CyclinE1, CyclinD1 in the tissues of esophageal squamous cell carcinoma was correlated with AKAP95, respectively. The expression of AKAP95, Cx43, CyclinE1 and CyclinD1 in the tissues of esophageal squamous cell carcinoma was unrelated to the degree of differentiation and lymph node metastasis.

Entities:  

Keywords:  AKAP95; Cx43; CyclinD1; CyclinE1; Esophageal cancer; correlation analyses

Year:  2015        PMID: 26221272      PMCID: PMC4509217     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  A connexin 43 mutant lacking the carboxyl cytoplasmic domain inhibits both growth and motility of mouse 3T3 fibroblasts.

Authors:  C D Moorby
Journal:  Mol Carcinog       Date:  2000-05       Impact factor: 4.784

2.  Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome.

Authors:  Solveig Sirnes; Jarle Bruun; Matthias Kolberg; Ane Kjenseth; Guro E Lind; Aud Svindland; Andreas Brech; Arild Nesbakken; Ragnhild A Lothe; Edward Leithe; Edgar Rivedal
Journal:  Int J Cancer       Date:  2011-10-20       Impact factor: 7.396

3.  Downregulation of connexin 43 in nasopharyngeal carcinoma cells is related to promoter methylation.

Authors:  Zong-Chun Yi; Hong Wang; Guang-Yao Zhang; Bing Xia
Journal:  Oral Oncol       Date:  2007-02-15       Impact factor: 5.337

4.  A-kinase-anchoring protein 95 functions as a potential carrier for the nuclear translocation of active caspase 3 through an enzyme-substrate-like association.

Authors:  Shinji Kamada; Ushio Kikkawa; Yoshihide Tsujimoto; Tony Hunter
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

5.  [Expression of A-kinase anchor protein 95, cyclin E2, and connexin 43 in lung cancer tissue, clinical significance of their expression, and their expression correlation].

Authors:  Yi-de Chen; Xiao-xuan Chen; Li-na Shen; Feng-chao Liang; Ye Ding; Xiu-yi Yu; Mao-qiang Xue; Yong-xing Zhang
Journal:  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi       Date:  2012-10

6.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Authors:  C Elizabeth Caldon; Elizabeth A Musgrove
Journal:  Cell Div       Date:  2010-01-17       Impact factor: 5.130

7.  Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105.

Authors:  Estelle A Wall; Joelle R Zavzavadjian; Mi Sook Chang; Baljinder Randhawa; Xiaocui Zhu; Robert C Hsueh; Jamie Liu; Adrienne Driver; Xiaoyan Robert Bao; Paul C Sternweis; Melvin I Simon; Iain D C Fraser
Journal:  Sci Signal       Date:  2009-06-16       Impact factor: 8.192

8.  The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.

Authors:  Martin Lodén; Maria Stighall; Niels Hilmer Nielsen; Göran Roos; Stefan O Emdin; Hanna Ostlund; Göran Landberg
Journal:  Oncogene       Date:  2002-07-11       Impact factor: 9.867

9.  Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication.

Authors:  Turid Eide; Kristin A Taskén; Cathrine Carlson; Gareth Williams; Tore Jahnsen; Kjetil Taskén; Philippe Collas
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

10.  [Relationship between AKAP95, cyclin E1, cyclin D1, and clinicopathological parameters in lung cancer tissue].

Authors:  Su-xian Hu; Xiang-yu Kong; Yang-yang Yuan; Bo-gang Teng; Xue-hong Zhi; Wen-xin Zhuang; Xiu-yi Yu; Wen-zhi Liu; Yong-xing Zhang
Journal:  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi       Date:  2013-12
View more
  10 in total

1.  Knockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells.

Authors:  Yiling Wang; Jiantao He; Shenghui Zhang; Qingbo Yang; Bo Wang; Zhiyu Liu; Xintian Wu
Journal:  Technol Cancer Res Treat       Date:  2016-07-13

2.  AKAP95 Organizes a Nuclear Microdomain to Control Local cAMP for Regulating Nuclear PKA.

Authors:  Terri Clister; Eric C Greenwald; George S Baillie; Jin Zhang
Journal:  Cell Chem Biol       Date:  2019-04-11       Impact factor: 8.116

3.  Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway.

Authors:  Suolin Zhang; Yayan Wang
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

4.  CyclinD1 promotes lymph node metastasis by inducing lymphangiogenesis in human ovarian carcinoma.

Authors:  Minhua Li; Weiping Zheng; Cheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

5.  Epac1, PDE4, and PKC protein expression and their correlation with AKAP95 and Cx43 in esophagus cancer tissues.

Authors:  Zhiyu Guan; Winxin Zhuang; Hui Lei; Dai Wang; Youliang Yao; Dongbei Guo; Qian Sun; Yun Chen; Xiaoyi Chen; Hongyan Lin; Bogang Teng; Yongxing Zhang
Journal:  Thorac Cancer       Date:  2017-08-03       Impact factor: 3.500

6.  Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6.

Authors:  Mi Gong; Chengyan Luo; Huangyang Meng; Siyue Li; Sipei Nie; Yi Jiang; Yicong Wan; Huijian Li; Wenjun Cheng
Journal:  Onco Targets Ther       Date:  2019-11-20       Impact factor: 4.147

7.  High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma.

Authors:  Qiu-Yun Luo; Tian Di; Miao-Zhen Qiu; Zeng-Fei Xia; Yong Du; Run-Duan Lin; Li-Qiong Yang; Yu-Ting Sun; Da-Jun Yang; Jian Sun; Lin Zhang
Journal:  Cancer Cell Int       Date:  2022-02-21       Impact factor: 5.722

8.  Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells.

Authors:  Xiaoxuan Chen; Xiangyu Kong; Wenxin Zhuang; Bogang Teng; Xiuyi Yu; Suhang Hua; Su Wang; Fengchao Liang; Dan Ma; Suhui Zhang; Xuan Zou; Yue Dai; Wei Yang; Yongxing Zhang
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

9.  Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.

Authors:  Yijun Liu; Qingluan Liu; Zhicheng Wang; Meilin Chen; Yi Chen; Xiayu Li; Donghai Huang; Songqing Fan; Wei Xiong; Guiyuan Li; Wenling Zhang
Journal:  J Clin Lab Anal       Date:  2020-07-22       Impact factor: 2.352

10.  Downregulation of CREB Promotes Cell Proliferation by Mediating G1/S Phase Transition in Hodgkin Lymphoma.

Authors:  Fangjin Lu; Ying Zheng; Paul Owusu Donkor; Peng Zou; Ping Mu
Journal:  Oncol Res       Date:  2016       Impact factor: 5.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.